Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
KERAJAKS M
- Development stage
- Unknown
- Lead developer
- AKS Pharma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
KERAJAKS M is an oral hair growth stimulant developed and marketed by AKS Pharma. Classified as a nutraceutical or dietary supplement, it is formulated as a tablet containing a combination of melatonin, biotin, amino acids, vitamins, and minerals. The product is designed to address hair loss (alopecia) by providing nutritional support and leveraging the biological effects of melatonin on the hair follicle. Melatonin is believed to influence the hair cycle by extending the anagen (growth) phase and protecting follicles from oxidative stress. Biotin and amino acids provide the necessary structural components for the production of keratin, the primary protein in hair. KERAJAKS M is typically used in dermatology and aesthetic medicine as an adjunct therapy for various types of hair thinning and hair fall.
- Brand names
- KERAJAKS M
- Other names
- KERAJAKS M Tablets
02
Targets
MTNR1B (Melatonin Receptor 2)MTNR1A (MT1)
Beyond the preview
Go deeper on KERAJAKS M.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on KERAJAKS M.